This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
GeoVax advances Gedeptin, a gene therapy designed to enhance checkpoint inhibitor response in immunologically cold tumors. Planned neoadjuvant study in head and neck cancer could expand combination immunotherapy options. #Oncology #Immunotherapy
2026-05-15T02:28:49.472Z